{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:31Z","timestamp":1762900411526},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-023-02519-6","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T21:04:27Z","timestamp":1675976667000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Facile Technology for Extemporaneous Preparation of Long-Acting Injectable Microparticulate Suspensions at the Patient Side"],"prefix":"10.1208","volume":"24","author":[{"given":"Sukhada S.","family":"Shevade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maharukh T.","family":"Rustomjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma V.","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"2519_CR1","doi-asserted-by":"publisher","unstructured":"Burgess DJ, Wright JC. An introduction to long acting injections and implants. In: Wright JC, Burgess DJ, editors. Long Acting Injections and Implants [Internet]. Boston, MA: Springer US; 2012. p. 1\u20139. Available from: https:\/\/doi.org\/10.1007\/978-1-4614-0554-2_1.","DOI":"10.1007\/978-1-4614-0554-2_1"},{"key":"2519_CR2","doi-asserted-by":"publisher","unstructured":"Wang Y, Burgess DJ. Microsphere technologies. In: Long Acting Injections and Implants [Internet]. Boston, MA: Springer US; 2012. p. 167\u201394. Available from: https:\/\/doi.org\/10.1007\/978-1-4614-0554-2_10.","DOI":"10.1007\/978-1-4614-0554-2_10"},{"issue":"107","key":"2519_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2016.05.020","volume":"15","author":"BK Lee","year":"2016","unstructured":"Lee BK, Yun Y, Park K. PLA micro- and nano-particles. Adv Drug Deliv Rev. 2016;15(107):176\u201391. https:\/\/doi.org\/10.1016\/j.addr.2016.05.020.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2519_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/02652049009021842","volume":"7","author":"R Jalil","year":"1990","unstructured":"Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul. 1990;7(3):297\u2013325. https:\/\/doi.org\/10.3109\/02652049009021842.","journal-title":"J Microencapsul"},{"issue":"1","key":"2519_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0378-5173(00)00363-X","volume":"200","author":"B Baras","year":"2000","unstructured":"Baras B, Benoit MA, Gillard J. Parameters influencing the antigen release from spray-dried poly (DL-lactide) microparticles. Int J Pharm. 2000;200(1):133\u201345. https:\/\/doi.org\/10.1016\/S0378-5173(00)00363-X.","journal-title":"Int J Pharm"},{"issue":"4","key":"2519_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40005-019-00449-9","volume":"49","author":"WY Lee","year":"2019","unstructured":"Lee WY, Asadujjaman M, Jee JP. Long acting injectable formulations: the state of the arts and challenges of poly (lactic-co-glycolic acid) microsphere, hydrogel, organogel and liquid crystal. J Pharm Investig. 2019;49(4):459\u201376. https:\/\/doi.org\/10.1007\/s40005-019-00449-9.","journal-title":"J Pharm Investig"},{"issue":"2","key":"2519_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5731\/pdajpst.2014.00955","volume":"68","author":"F Hasanain","year":"2014","unstructured":"Hasanain F, Guenther K, Mullett WM, Craven E. Gamma sterilization of pharmaceuticals\u2014a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations. PDA J Pharm Sci Technol. 2014;68(2):113\u201337. https:\/\/doi.org\/10.5731\/pdajpst.2014.00955.","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"2519_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/BF03218376","volume":"11","author":"JS Lee","year":"2003","unstructured":"Lee JS, Chae GS, Khang G, Kim MS, Cho SH, Lee HB. The effect of gamma irradiation on PLGA and release behavior of BCNU from PLGA wafer. Macromol Res. 2003;11(5):352\u20136. https:\/\/doi.org\/10.1007\/BF03218376.","journal-title":"Macromol Res"},{"key":"2519_CR9","unstructured":"Bodmeier R. Multiphase system.   EP0996426A1, 2000 May 03. https:\/\/patents.google.com\/patent\/EP0996426A1\/en."},{"key":"2519_CR10","first-page":"414","volume":"1","author":"H Kranz","year":"1998","unstructured":"Kranz H, Bodmeier R. A biodegradable in situ forming system for controlled drug release. Pharm Sci Suppl. 1998;1:414.","journal-title":"Pharm Sci Suppl"},{"issue":"1","key":"2519_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0378-5173(00)00568-8","volume":"212","author":"H Kranz","year":"2001","unstructured":"Kranz H, Brazeau GA, Napaporn J, Martin RL, Millard W, Bodmeier R. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems. Int J Pharm. 2001;212(1):11\u20138. https:\/\/doi.org\/10.1016\/S0378-5173(00)00568-8.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2519_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpharm.2006.09.033","volume":"332","author":"H Kranz","year":"2007","unstructured":"Kranz H, Bodmeier R. A novel in situ forming drug delivery system for controlled parenteral drug delivery. Int J Pharm. 2007;332(1\u20132):107\u201314. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.09.033.","journal-title":"Int J Pharm"},{"key":"2519_CR13","doi-asserted-by":"publisher","unstructured":"K\u00f6rber M, Bodmeier R. Development of an in situ forming PLGA drug delivery system: I. Characterization of a non-aqueous protein precipitation. European Journal of Pharmaceutical Sciences. 2008 Nov 15;35(4):283\u2013292. https:\/\/doi.org\/10.1016\/j.ejps.2008.07.007.","DOI":"10.1016\/j.ejps.2008.07.007"},{"issue":"2\u20133","key":"2519_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejps.2005.09.002","volume":"27","author":"X Luan","year":"2006","unstructured":"Luan X, Bodmeier R. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters. Eur J Pharm Sci. 2006;27(2\u20133):143\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2005.09.002.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"2519_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1248\/cpb.56.796","volume":"56","author":"J Li","year":"2008","unstructured":"Li J, Chen F, Hu C, He L, Yan K, Zhou L, et al. Optimized preparation of in situ forming microparticles for the parenteral delivery of vinpocetine. Chem Pharm Bull. 2008;56(6):796\u2013801. https:\/\/doi.org\/10.1248\/cpb.56.796.","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"2519_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/ph14010066","volume":"14","author":"M Haider","year":"2021","unstructured":"Haider M, Elsayed I, Ahmed IS, Fares AR. In situ-forming microparticles for controlled release of rivastigmine: in vitro optimization and in vivo evaluation. Pharmaceuticals. 2021;14(1):66. https:\/\/doi.org\/10.3390\/ph14010066.","journal-title":"Pharmaceuticals"},{"key":"2519_CR17","doi-asserted-by":"publisher","unstructured":"Parent M, Boudier A, Perrin J, Vigneron C, Maincent P, Violle N, et al. In situ microparticles loaded with s-nitrosoglutathione protect from stroke. PLoS ONE. 2015 Dec 8;10(12):e0144659. https:\/\/doi.org\/10.1371\/journal.pone.0144659.","DOI":"10.1371\/journal.pone.0144659"},{"issue":"2","key":"2519_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ijpharm.2015.10.070","volume":"496","author":"AA D\u2019Souza","year":"2015","unstructured":"D\u2019Souza AA, Yevate SV, Bandivdekar A, Devarajan PV. In situ polyethylene sebacate particulate carriers as an alternative to Freund\u2019s adjuvant for delivery of a contraceptive peptide vaccine\u2014a feasibility study. Int J Pharm. 2015;496(2):601\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.10.070.","journal-title":"Int J Pharm"},{"issue":"1","key":"2519_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpharm.2012.02.042","volume":"429","author":"SV Kapse","year":"2012","unstructured":"Kapse SV, Gaikwad RV, Samad A, Devarajan PV. Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability. Int J Pharm. 2012;429(1):104\u201312. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.02.042.","journal-title":"Int J Pharm"},{"key":"2519_CR20","doi-asserted-by":"publisher","unstructured":"John R, Dalal B, Shankarkumar A, Devarajan PV. Innovative betulin nanosuspension exhibits enhanced anticancer activity in a triple negative breast cancer cell line and zebrafish angiogenesis model. International Journal of Pharmaceutics. 2021 May 1;600:120511. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120511.","DOI":"10.1016\/j.ijpharm.2021.120511"},{"issue":"4","key":"2519_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13346-014-0200-4","volume":"4","author":"VM Joshi","year":"2014","unstructured":"Joshi VM, Devarajan PV. Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand. Drug Deliv Transl Res. 2014;4(4):353\u201364. https:\/\/doi.org\/10.1007\/s13346-014-0200-4.","journal-title":"Drug Deliv Transl Res"},{"issue":"1\u20132","key":"2519_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijpharm.2017.02.024","volume":"521","author":"AB Jindal","year":"2017","unstructured":"Jindal AB, Bachhav SS, Devarajan PV. In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept. Int J Pharm. 2017;521(1\u20132):196\u2013203. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.024.","journal-title":"Int J Pharm"},{"issue":"1","key":"2519_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/btm2.10112","volume":"4","author":"PS Jahagirdar","year":"2019","unstructured":"Jahagirdar PS, Gupta PK, Kulkarni SP, Devarajan PV. Polymeric curcumin nanoparticles by a facile in situ method for macrophage targeted delivery. Bioengineering & Translational Medicine. 2019;4(1):141\u201351. https:\/\/doi.org\/10.1002\/btm2.10112.","journal-title":"Bioengineering & Translational Medicine"},{"issue":"1","key":"2519_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijpharm.2015.04.073","volume":"489","author":"AB Jindal","year":"2015","unstructured":"Jindal AB, Devarajan PV. Asymmetric lipid\u2013polymer particles (LIPOMER) by modified nanoprecipitation: role of non-solvent composition. Int J Pharm. 2015;489(1):246\u201351. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.04.073.","journal-title":"Int J Pharm"},{"key":"2519_CR25","unstructured":"Van Krevelen DW, Te Nijenhuis K. Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. Elsevier; 2009."},{"issue":"18","key":"2519_CR26","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/polb.24383","volume":"55","author":"WH Ferrell","year":"2017","unstructured":"Ferrell WH, Kushner DI, Hickner MA. Investigation of polymer\u2013solvent interactions in poly (styrene sulfonate) thin films. J Polym Sci, Part B: Polym Phys. 2017;55(18):1365\u201372. https:\/\/doi.org\/10.1002\/polb.24383.","journal-title":"J Polym Sci, Part B: Polym Phys"},{"issue":"1\u20132","key":"2519_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.07.015","volume":"397","author":"Q Liu","year":"2010","unstructured":"Liu Q, Zhang H, Zhou G, Xie S, Zou H, Yu Y, et al. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly (lactide-co-glycolide) implants. Int J Pharm. 2010;397(1\u20132):122\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.07.015.","journal-title":"Int J Pharm"},{"issue":"10","key":"2519_CR28","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1002\/jps.23250","volume":"101","author":"TA Ahmed","year":"2012","unstructured":"Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, et al. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol. J Pharm Sci. 2012;101(10):3753\u201362. https:\/\/doi.org\/10.1002\/jps.23250.","journal-title":"J Pharm Sci"},{"key":"2519_CR29","doi-asserted-by":"publisher","unstructured":"D\u2019Souza SS, DeLuca PP. Development of a dialysis in vitro release method for biodegradable microspheres. AAPS pharmscitech. 2005;6(2):E323-E328. https:\/\/doi.org\/10.1208\/pt060242.","DOI":"10.1208\/pt060242"},{"issue":"16","key":"2519_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/00914037.2018.1525541","volume":"68","author":"H Kamali","year":"2019","unstructured":"Kamali H, Khodaverdi E, Hadizadeh F, Mohajeri SA, Kamali Y, Jafarian AH. In-vitro, ex-vivo, and in-vivo release evaluation of in situ forming buprenorphine implants using mixture of PLGA copolymers and additives. Int J Polym Mater Polym Biomater. 2019;68(16):965\u201377. https:\/\/doi.org\/10.1080\/00914037.2018.1525541.","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"123","key":"2519_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2017.11.002","volume":"1","author":"S Dawre","year":"2018","unstructured":"Dawre S, Pathak S, Sharma S, Devarajan PV. Enhanced antimalalarial activity of a prolonged release in situ gel of arteether\u2013lumefantrine in a murine model. Eur J Pharm Biopharm. 2018;1(123):95\u2013107. https:\/\/doi.org\/10.1016\/j.ejpb.2017.11.002.","journal-title":"Eur J Pharm Biopharm"},{"key":"2519_CR32","unstructured":"Stainmesse S, Fessi H, Devissaguet  J-P, Puisieux F, Theis C. Process for preparing dispersible colloidal systems of a substance in nanoparticulate form. US5133908A, 1992 July 28. https:\/\/patents.google.com\/patent\/US5133908A\/en."},{"key":"2519_CR33","doi-asserted-by":"publisher","unstructured":"Joshi HA, Patwardhan RS, Sharma D, Sandur SK, Devarajan PV. Pre-clinical evaluation of an innovative oral nano-formulation of baicalein for modulation of radiation responses. International Journal of Pharmaceutics. 2021 Feb 15;595:120181. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.120181.","DOI":"10.1016\/j.ijpharm.2020.120181"},{"key":"2519_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/DDDT.S287323","volume":"15","author":"AV Badkar","year":"2021","unstructured":"Badkar AV, Gandhi RB, Davis SP, LaBarre MJ. Subcutaneous delivery of high-dose\/volume biologics: current status and prospect for future advancements. DDDT. 2021;15:159\u201370. https:\/\/doi.org\/10.2147\/DDDT.S287323.","journal-title":"DDDT"},{"issue":"1","key":"2519_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(96)04828-4","volume":"148","author":"BC Hancock","year":"1997","unstructured":"Hancock BC, York P, Rowe RC. The use of solubility parameters in pharmaceutical dosage form design. Int J Pharm. 1997;148(1):1\u201321. https:\/\/doi.org\/10.1016\/S0378-5173(96)04828-4.","journal-title":"Int J Pharm"},{"issue":"107","key":"2519_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.addr.2016.07.002","volume":"15","author":"A Jain","year":"2016","unstructured":"Jain A, Kunduru KR, Basu A, Mizrahi B, Domb AJ, Khan W. Injectable formulations of poly(lactic acid) and its copolymers in clinical use. Adv Drug Deliv Rev. 2016;15(107):213\u201327. https:\/\/doi.org\/10.1016\/j.addr.2016.07.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"2519_CR37","doi-asserted-by":"publisher","unstructured":"Lancheros R, Guerrero CA, Godoy-Silva RD. Improvement of N-acetylcysteine loaded in PLGA nanoparticles by nanoprecipitation method. Journal of Nanotechnology. 2018 Jan 1;2018:https:\/\/doi.org\/10.1155\/2018\/3620373.","DOI":"10.1155\/2018\/3620373"},{"issue":"1\u20132","key":"2519_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijpharm.2007.05.054","volume":"344","author":"P Legrand","year":"2007","unstructured":"Legrand P, Lesieur S, Bochot A, Gref R, Raatjes W, Barratt G, et al. Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. Int J Pharm. 2007;344(1\u20132):33\u201343. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.05.054.","journal-title":"Int J Pharm"},{"issue":"71","key":"2519_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.addr.2013.12.009","volume":"1","author":"E Lepeltier","year":"2014","unstructured":"Lepeltier E, Bourgaux C, Couvreur P. Nanoprecipitation and the \u201cOuzo effect\u201d: application to drug delivery devices. Adv Drug Deliv Rev. 2014;1(71):86\u201397. https:\/\/doi.org\/10.1016\/j.addr.2013.12.009.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"2519_CR40","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1023\/B:PHAM.0000036917.75634.be","volume":"21","author":"S Galindo-Rodriguez","year":"2004","unstructured":"Galindo-Rodriguez S, All\u00e9mann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 2004;21(8):1428\u201339. https:\/\/doi.org\/10.1023\/B:PHAM.0000036917.75634.be.","journal-title":"Pharm Res"},{"issue":"1","key":"2519_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.08.064","volume":"532","author":"CJ Rivas","year":"2017","unstructured":"Rivas CJ, Tarhini M, Badri W, Miladi K, Greige-Gerges H, Nazari QA, et al. Nanoprecipitation process: from encapsulation to drug delivery. Int J Pharm. 2017;532(1):66\u201381. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.064.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2519_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems\u2014a review. Int J Pharm. 2011;415(1\u20132):34\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.05.049.","journal-title":"Int J Pharm"},{"issue":"2","key":"2519_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jconrel.2010.03.024","volume":"146","author":"G Acharya","year":"2010","unstructured":"Acharya G, Shin CS, Vedantham K, McDermott M, Rish T, Hansen K, et al. A study of drug release from homogeneous PLGA microstructures. J Control Release. 2010;146(2):201\u20136. https:\/\/doi.org\/10.1016\/j.jconrel.2010.03.024.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"2519_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijpharm.2007.04.025","volume":"342","author":"XS Li","year":"2007","unstructured":"Li XS, Wang JX, Shen ZG, Zhang PY, Chen JF, Yun J. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. Int J Pharm. 2007;342(1\u20132):26\u201332. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.04.025.","journal-title":"Int J Pharm"},{"key":"2519_CR45","doi-asserted-by":"publisher","unstructured":"Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi AHomayouni. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques. Colloids Surf B. 2014 Oct 1;122:591\u2013600. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.07.037.","DOI":"10.1016\/j.colsurfb.2014.07.037"},{"issue":"5","key":"2519_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajps.2015.06.001","volume":"10","author":"W Guo","year":"2015","unstructured":"Guo W, Quan P, Fang L, Cun D, Yang M. Sustained release donepezil loaded PLGA microspheres for injection: preparation, in vitro and in vivo study. Asian J Pharm Sci. 2015;10(5):405\u201314. https:\/\/doi.org\/10.1016\/j.ajps.2015.06.001.","journal-title":"Asian J Pharm Sci"},{"issue":"11","key":"2519_CR47","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1007\/s11095-017-2240-1","volume":"34","author":"N Mittapelly","year":"2017","unstructured":"Mittapelly N, Thalla M, Pandey G, Banala VT, Sharma S, Arya A, et al. Long acting ionically paired embonate based nanocrystals of donepezil for the treatment of Alzheimer\u2019s disease: a proof of concept study. Pharm Res. 2017;34(11):2322\u201335. https:\/\/doi.org\/10.1007\/s11095-017-2240-1.","journal-title":"Pharm Res"},{"issue":"1","key":"2519_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.xphs.2019.10.033","volume":"109","author":"E Krayukhina","year":"2020","unstructured":"Krayukhina E, Fukuhara A, Uchiyama S. Assessment of the injection performance of a tapered needle for use in prefilled biopharmaceutical products. J Pharm Sci. 2020;109(1):515\u201323. https:\/\/doi.org\/10.1016\/j.xphs.2019.10.033.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2519_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25\u201335. https:\/\/doi.org\/10.1016\/0378-5173(83)90064-9.","journal-title":"Int J Pharm"},{"issue":"178","key":"2519_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113912","volume":"1","author":"X Wang","year":"2021","unstructured":"Wang X, Burgess DJ. Drug release from in situ forming implants and advances in release testing. Adv Drug Deliv Rev. 2021;1(178): 113912.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-023-02519-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:05:51Z","timestamp":1676300751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-023-02519-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1208\/s12249-023-02519-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"61"}}